Entera Bio Ltd. Warrant
ENTXW
ENTXW was delisted on the 27th of June, 2023.
4 hedge funds and large institutions have $160K invested in Entera Bio Ltd. Warrant in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
493% more capital invested
Capital invested by funds: $27K → $160K (+$133K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
+$55.4K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$4.76K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$745 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$9K |
ENTXW Hedge Fund Activity: Q2 2021 in Review
4 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Entera Bio Ltd. Warrant (ENTXW) for Q2 2021, worth a combined $160K — up 493% from $27K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ENTXW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Ionic Capital Management, opening a new position worth an estimated $55.4K. The largest seller was Virtu Financial, exiting entirely with an estimated $9K sold.
- 4 institutional investors held Entera Bio Ltd. Warrant (ENTXW) as of Q2 2021, up from 3 in Q1 2021.
- Funds reported $160K of Entera Bio Ltd. Warrant stock for Q2 2021, up 493% quarter-over-quarter.
- 2 funds opened new Entera Bio Ltd. Warrant positions in Q2 2021 and 1 closed out, a net change of +1 holder.
- The largest Entera Bio Ltd. Warrant buyer in Q2 2021 was Ionic Capital Management, an estimated $55.4K added.
- The largest Entera Bio Ltd. Warrant seller in Q2 2021 was Virtu Financial, an estimated $9K sold.
Based on aggregated 13F filings for Q2 2021.